Evidence map›Paper›PMID 41743161›Full record

ArticleMaterials today. Bio2026

Systemic Immunity Triggered by Boron Neutron Capture Therapy via Manganese-Borate Complex.

Chang Chen, Chao Wang, Lin Zhang, Yue Yu, Xu Li, Wenhao Pan, Yuanyu Liu, Jiheng Wang, Maosong Yang, Bing Hong and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Chang ChenInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Chao WangDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Lin ZhangState key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, 230026, China.
Yue YuDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Xu LiInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Wenhao PanState key Laboratory of Precision and Intelligent Chemistry, Department of Polymer Science and Engineering, School of Chemistry and Materials Science, University of Science and Technology of China, Hefei, 230026, China.
Yuanyu LiuInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Jiheng WangInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Maosong YangInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Bing HongInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Xingguang HuInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Jichao WangInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Yuzhong QianInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Xiancai MengInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Yinghuai ZhuSunshine Lake Pharma Co. Ltd., Dongguan, 523871, China.
Zhigang LiuCancer Center, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Guangdong Engineering Research Center of Boron Neutron Therapy and Application in Malignant Tumors, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, China.
Shaobo HuangCancer Center, Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Guangdong Engineering Research Center of Boron Neutron Therapy and Application in Malignant Tumors, The Tenth Affiliated Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, 523059, China.
Lizheng LiangInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.
Jinhui WuDepartment of General Surgery, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, 210008, China.
Yang LiuInstitute of Energy, Hefei Comprehensive National Science Center (Anhui Energy Laboratory), Hefei, Anhui, 230031, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conventional radiotherapy compromises antitumor immunity through collateral damage to immune cells. While boron neutron capture therapy (BNCT) enables tumor-selective

Indexed as

AlbuminBiomineralizedBoron neutron capture therapyEnergy Starvation.ImmunotherapyRadiotherapy

Identifiers

PMID41743161
PMCPMC12930067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.